Skip to main content
Fig. 3 | Journal of Patient-Reported Outcomes

Fig. 3

From: Qualitative interviews of patients with COPD and muscle weakness enrolled in a clinical trial evaluating a new anabolic treatment: patient perspectives of disease experience, trial participation and outcome assessments

Fig. 3

Overview of (A) symptoms and (B) functional limitationsa. aReported by participants during the 60-minute (n = 32) and 15-minute exit interviews (n = 35) at the start of the trial. The remaining participants were either not questioned regarding the relevant symptom or limitation, or did not spontaneously mention it during the interview

Back to article page